12,744
Total Claims
$1.8M
Drug Cost
2,122
Beneficiaries
$869
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-26%
Cost per patient vs peers
$869 vs $1,174 avg
+77%
Brand preference vs peers
15.7% vs 8.9% avg
Brand vs Generic
84% generic
Brand: 2,004 claims · $1.6M
Generic: 10,740 claims · $289K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 934 | $827K |
| Sacubitril/Valsartan | 241 | $268K |
| Rivaroxaban | 183 | $204K |
| Evolocumab | 61 | $54K |
| Evolocumab | 60 | $49K |
| Ambrisentan | 11 | $44K |
| Alirocumab | 62 | $40K |
| Ticagrelor | 41 | $32K |
| Metoprolol Succinate | 1,393 | $30K |
| Dronedarone Hcl | 12 | $19K |
| Ivabradine Hcl | 16 | $17K |
| Ranolazine | 84 | $16K |
| Atorvastatin Calcium | 795 | $12K |
| Potassium Chloride | 431 | $12K |
| Bempedoic Acid | 15 | $12K |
Prescribing Profile
75
Unique Drugs
$1.3M
Patient Profile
76
Avg Age
57%
Female
1.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data